Valvular Heart Disease
Conditions
Brief summary
Patients undergoing transcatheter valvular interventions will be prospectively included into the present registry. Baseline, procedural and follow-up data will be collected and analyzed to adress various issues in the field of percutaneous valvular interventions.
Interventions
Transcatheter valvular repair (predominantly MitraClip for mitral regurgitation) or replacement (predominantly transcatheter aortic valve implantation for aortic stenosis)
Sponsors
Study design
Eligibility
Inclusion criteria
\- Severe valvular defect planned for valvular intervention
Exclusion criteria
\- No informed consent
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| All-cause mortality | 10 years |
Secondary
| Measure | Time frame |
|---|---|
| Cardiovascular mortality | 10 years |
| NYHA status | 10 years |
| Grade of mitral regurgitation | 10 years |
Countries
Germany